Publication | Open Access

Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie

Surgical OncologyEsophageal CancerGastrointestinal OncologyMedicinePathologyEsophagogastric JunctionCancer TreatmentOncologyRadiation OncologyBiweekly FluorouracilCancer ResearchMetastatic Adenocarcinoma